Cargando…

Healthcare Costs Before and After Diagnosis of Cancer of Unknown Primary Versus Ovarian Cancer in Australia

BACKGROUND: Little is known about the healthcare resource usage and costs for patients with cancer of unknown primary (CUP). OBJECTIVE: The aim of this study was to describe and quantify healthcare resource use and costs in Australia, 6 months prior to and after a diagnosis of CUP, and compare to th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gordon, Louisa G., Wood, C., Tothill, R. W., Webb, P. M., Schofield, P., Mileshkin, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929003/ https://www.ncbi.nlm.nih.gov/pubmed/36253664 http://dx.doi.org/10.1007/s41669-022-00371-1

Ejemplares similares

Psychological distress, understanding of cancer and illness uncertainty in patients with Cancer of Unknown Primary
por: Wolyniec, Kamil, et al.
Publicado: (2022)

Six-year experience of Australia’s first dedicated cancer of unknown primary clinic
por: van Mourik, Arielle, et al.
Publicado: (2023)

Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary
por: Posner, Atara, et al.
Publicado: (2023)

Uncertainty and the unmet informational needs of patients with cancer of unknown primary (CUP): a cross-sectional multi-site study
por: Guccione, Lisa, et al.
Publicado: (2022)

A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary
por: Posner, Atara, et al.
Publicado: (2022)

Estimated Healthcare Costs of Melanoma and Keratinocyte Skin Cancers in Australia and Aotearoa New Zealand in 2021
por: Gordon, Louisa G., et al.
Publicado: (2022)

Differences in experiences of care between patients diagnosed with metastatic cancer of known and unknown primaries: mixed-method findings from the 2013 cancer patient experience survey in England
por: Wagland, Richard, et al.
Publicado: (2017)

Health services costs for ovarian cancer in Australia: Estimates from the 45 and Up Study
por: Goldsbury, David E., et al.
Publicado: (2023)

Modelling the healthcare costs of skin cancer in South Africa
por: Gordon, Louisa G., et al.
Publicado: (2016)

Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities
por: Urban, D, et al.
Publicado: (2013)

Cancer: An unknown territory; rethinking before going ahead
por: Upadhyay, Arun
Publicado: (2020)

Review: Mechanotransduction in ovarian cancer: Shearing into the unknown
por: Novak, Caymen, et al.
Publicado: (2018)

Estimating the costs of genomic sequencing in cancer control
por: Gordon, Louisa G., et al.
Publicado: (2020)

The Productivity Costs of Premature Mortality Due to Cancer in Australia: Evidence from a Microsimulation Model
por: Carter, Hannah E., et al.
Publicado: (2016)

Cost of gastroenteritis in Australia: A healthcare perspective
por: Barker, S. Fiona, et al.
Publicado: (2018)

A comparison of the direct medical costs for individuals with or without basal or squamous cell skin cancer: A study from Australia
por: Rowell, David, et al.
Publicado: (2016)

Healthcare use and clinical investigations before a diagnosis of ovarian cancer: a register-based study in Denmark
por: Rousing, Isabella Gringer, et al.
Publicado: (2023)

Experience and Expectations of Ovarian Cancer Patients in Australia
por: Holliday, Catherine M., et al.
Publicado: (2018)

Relationship between use of general practice and healthcare costs at the end of life: a data linkage study in New South Wales, Australia
por: Tran, Bich, et al.
Publicado: (2016)

Cancer Survivors’ Long-Term Health Service Costs in Queensland, Australia: Results of a Population-Level Data Linkage Study (Cos-Q)
por: Merollini, Katharina M. D., et al.
Publicado: (2022)

Cost of dialysis therapies in rural and remote Australia – a micro-costing analysis
por: Gorham, G., et al.
Publicado: (2019)

Whole Grain Intakes Are Associated with Healthcare Cost Savings Following Reductions in Risk of Colorectal Cancer and Total Cancer Mortality in Australia: A Cost-of-Illness Model
por: Abdullah, Mohammad M. H., et al.
Publicado: (2021)

Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: design and implementation of a randomised controlled trial
por: Hayes, Sandra, et al.
Publicado: (2023)

Discussing and prescribing expensive unfunded anticancer drugs in Australia
por: Karikios, Deme John, et al.
Publicado: (2017)

Lifetime Costs of Surviving Cancer—A Queensland Study (COS-Q): Protocol of a Large Healthcare Data Linkage Study
por: Merollini, Katharina M. D., et al.
Publicado: (2020)

A steep increase in healthcare seeking behaviour in the last months before colorectal cancer diagnosis
por: Kuiper, Josephina G., et al.
Publicado: (2021)

Increased healthcare costs by later stage cancer diagnosis
por: McGarvey, November, et al.
Publicado: (2022)

Cancer-of-Unknown-Primary-Origin: A SEER–Medicare Study of Patterns of Care and Outcomes among Elderly Patients in Clinical Practice
por: Mileshkin, Linda, et al.
Publicado: (2022)

Healthcare use and costs before and after parathyroidectomy in patients on dialysis
por: Belozeroff, Vasily, et al.
Publicado: (2013)

The burden of cancer on primary and secondary health care services before and after cancer diagnosis in New South Wales, Australia
por: Morrell, Stephen, et al.
Publicado: (2019)

The cost-effectiveness and consumer acceptability of taxation strategies to reduce rates of overweight and obesity among children in Australia: study protocol
por: Comans, Tracy A, et al.
Publicado: (2013)

Specialist consultation activity and costs in Australia: Before and after the introduction of COVID-19 telehealth funding
por: De Guzman, Keshia R, et al.
Publicado: (2021)

Japanese Encephalitis Virus in Australia: From Known Known to Known Unknown
por: van den Hurk, Andrew F., et al.
Publicado: (2019)

Approval, reimbursement and pricing of high-cost cancer medicines in Australia
por: Vitry, Agnes
Publicado: (2015)

Indirect costs of depression and other mental and behavioural disorders for Australia from 2015 to 2030
por: Schofield, Deborah, et al.
Publicado: (2019)

Liquid biopsy in ovarian cancer: Catching the silent killer before it strikes
por: Feeney, Laura, et al.
Publicado: (2020)

Healthcare Cost and Utilization before and after Diagnosis of Pseudomonas aeruginosa among Patients with Non-Cystic Fibrosis Bronchiectasis in the U.S.
por: Blanchette, Christopher M., et al.
Publicado: (2017)

Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site
por: Kodaira, Makoto, et al.
Publicado: (2018)

A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience
por: Pauli, Chantal, et al.
Publicado: (2021)

Financial Toxicity and Out-of-Pocket Costs for Patients with Head and Neck Cancer
por: Smith, Justin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1q42t16er6pb1ufco7a538c1kj